We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » BMS, AstraZeneca Collaborating on Two Diabetes Drugs
BMS, AstraZeneca Collaborating on Two Diabetes Drugs
January 11, 2007
Bristol-Myers Squibb (BMS) and AstraZeneca announced that they are collaborating to develop and commercialize two experimental drugs for Type 2 diabetes.